Related Experiment Video
Updated: Jun 9, 2026

12:36
Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
9.4K
Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1.
Isil Kucuka1, Dorsa Iraji1, Sarah Braun1
1Department of Clinical Science, Department of Medicine, University of Bergen, Bergen, Norway.
Scandinavian Journal of Immunology
|April 1, 2025
Summary
Autoimmune Polyendocrine Syndrome Type-1 (APS-1) is linked to altered immune cell distribution, particularly in young patients. Immune cell discrepancies in APS-1 patients are most pronounced early in life, impacting adaptive and innate immunity.
Area of Science:
- Immunology
- Genetics
- Endocrinology
Background:
- Autoimmune Polyendocrine Syndrome Type-1 (APS-1) is a rare autoimmune disorder caused by mutations in the autoimmune regulator (AIRE) gene.
- AIRE gene mutations lead to impaired T-cell selection and altered T regulatory cell populations, but immune cell subset dynamics across the lifespan in APS-1 are poorly understood.
Purpose of the Study:
- To investigate the peripheral distribution and longitudinal changes of 13 immune cell subsets across the lifespan in patients with APS-1.
- To identify age-related variations in immune cell composition in APS-1 and compare them to healthy individuals.
Main Methods:
- Epigenetic quantification was used to analyze the peripheral distribution of 13 immune cell subsets.
- Longitudinal analysis was performed to track changes in cell composition over time in APS-1 patients and healthy controls.
Main Results:
- The most significant differences in immune cell distribution were observed in young APS-1 patients, coinciding with the onset of clinical symptoms.
- Reduced frequencies of B cells, T-cell subgroups, nonclassical monocytes, and Natural Killer cells were found in young APS-1 patients.
- B-cell frequencies declined with age in both APS-1 patients and healthy controls, while Tregs, follicular helper T cells, and natural killer cells showed opposing age-related trends.
Conclusions:
- Immune cell subset dynamics in APS-1 vary significantly across the lifespan, with notable differences emerging early in life.
- The opposing age-related trends in specific immune cell populations highlight the importance of considering age-specific cohort profiles in APS-1 research to avoid conflicting interpretations.
More Related Videos
Related Concept Videos
Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

